Clustering and Rule-Based Classifications of Chemical Structures Evaluated in the Biological Activity Space
暂无分享,去创建一个
Jeremy L. Jenkins | Peter Ertl | Nathan Brown | Ansgar Schuffenhauer | Paul Selzer | Jacques Hamon | J. Jenkins | A. Schuffenhauer | P. Selzer | J. Hamon | P. Ertl | Nathan Brown
[1] A. Schuffenhauer,et al. Charting biologically relevant chemical space: a structural classification of natural products (SCONP). , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[2] Dragos Horvath,et al. Molecular similarity and property similarity. , 2004, Current topics in medicinal chemistry.
[3] Pierre Acklin,et al. Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins , 2003, J. Chem. Inf. Comput. Sci..
[4] Scott Boyer,et al. Chemical and biological profiling of an annotated compound library directed to the nuclear receptor family. , 2005, Current topics in medicinal chemistry.
[5] Gisbert Schneider,et al. NIPALSTREE: A New Hierarchical Clustering Approach for Large Compound Libraries and Its Application to Virtual Screening , 2006, J. Chem. Inf. Model..
[6] J. Jenkins,et al. A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes. , 2004, Journal of medicinal chemistry.
[7] Peter Willett,et al. Designing focused libraries using MoSELECT. , 2002, Journal of molecular graphics & modelling.
[8] Gisbert Schneider,et al. A Hierarchical Clustering Approach for Large Compound Libraries , 2005, J. Chem. Inf. Model..
[9] Marvin Johnson,et al. Concepts and applications of molecular similarity , 1990 .
[10] Christos A. Nicolaou,et al. Ties in Proximity and Clustering Compounds , 2001, J. Chem. Inf. Comput. Sci..
[11] Johann Gasteiger,et al. Neural networks in chemistry and drug design , 1999 .
[12] Jeffrey J. Sutherland,et al. Development of Quantitative Structure-Activity Relationships and Classification Models for Anticonvulsant Activity of Hydantoin Analogues , 2003, J. Chem. Inf. Comput. Sci..
[13] Robert D. Clark,et al. OptiSim: An Extended Dissimilarity Selection Method for Finding Diverse Representative Subsets , 1997, J. Chem. Inf. Comput. Sci..
[14] P. Furet,et al. Strategies toward the design of novel and selective protein tyrosine kinase inhibitors. , 1999, Pharmacology & therapeutics.
[15] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[16] Peter Ertl,et al. Applications of Self-Organizing Neural Networks in Virtual Screening and Diversity Selection , 2006, J. Chem. Inf. Model..
[17] Johann Gasteiger,et al. The Search for the Spatial and Electronic Requirements of a Drug , 2000 .
[18] Nathan Brown,et al. On scaffolds and hopping in medicinal chemistry. , 2006, Mini reviews in medicinal chemistry.
[19] J. Gasteiger,et al. Automatic generation of 3D-atomic coordinates for organic molecules , 1990 .
[20] A. Fliri,et al. Biological spectra analysis: Linking biological activity profiles to molecular structure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[21] Y. Martin,et al. Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.
[22] A. Ghose,et al. Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods , 1998 .
[23] James G. Nourse,et al. Reoptimization of MDL Keys for Use in Drug Discovery , 2002, J. Chem. Inf. Comput. Sci..
[24] P Willett,et al. Binning schemes for partition-based compound selection. , 1999, Journal of molecular graphics & modelling.
[25] Mark Johnson,et al. Using Molecular Equivalence Numbers To Visually Explore Structural Features that Distinguish Chemical Libraries , 2002, J. Chem. Inf. Comput. Sci..
[26] Dragos Horvath,et al. Predicting ADME properties and side effects: the BioPrint approach. , 2003, Current opinion in drug discovery & development.
[27] H. Halberstam,et al. Combinatorial Analysis , 1971, Nature.
[28] John M. Barnard,et al. Clustering Methods and Their Uses in Computational Chemistry , 2003 .
[29] P. Selzer,et al. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.
[30] L. Kelley,et al. An automated approach for clustering an ensemble of NMR-derived protein structures into conformationally related subfamilies. , 1996, Protein engineering.
[31] P. Willett,et al. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. , 2004, Organic & biomolecular chemistry.
[32] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[33] Peter Ertl,et al. Relationships between Molecular Complexity, Biological Activity, and Structural Diversity , 2006, J. Chem. Inf. Model..
[34] Stefan Wetzel,et al. The Scaffold Tree - Visualization of the Scaffold Universe by Hierarchical Scaffold Classification , 2007, J. Chem. Inf. Model..
[35] G. Schneider,et al. Scaffold‐Hopping Potential of Ligand‐Based Similarity Concepts , 2006, ChemMedChem.